Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 62 pages
Exam (elaborations)

NRG 200 FINAL EXAM NEWEST 2026 ACTUAL EXAM TEST BANK NRG200 PHARMACOLOGY FOR HUMAN CARING

Document preview thumbnail
Preview 4 out of 62 pages

This document is a test bank for the NRG 200 final exam, focusing on pharmacology for human caring. It contains practice exam questions and answers to help students prepare for the NRG200 pharmacology course final. The material covers key pharmacological concepts relevant to nursing and human care.

Content preview

NRG 200 FINAL EXAM NEWEST 2026 ACTUAL EXAM TEST BANK NRG200
PHARMACOLOGY FOR HUMAN CARING NURSING FINAL EXAM REVIEW
WITH COMPLETE 300 REAL EXAM QUESTIONS AND CORRECT VERIFIED
120 QUESTIONS




TABLE OF CONTENTS

# TOPIC

1 Analyze the pharmacokinetic and pharmacodynamic processes of major drug classes and their
implications for nursing care

2 Evaluate the safety, efficacy, and monitoring parameters of pharmacological therapies in complex clinical
scenarios

3 Integrate ethical, legal, and evidence-based principles into medication administration and patient
education

4 Apply advanced nursing judgment to prevent adverse drug events, interactions, and medication errors

5 NRG 200 FINAL EXAM NEWEST 2026 ACTUAL EXAM TEST BANK NRG200 PHARMACOLOGY FOR
HUMAN CARING NURSING FINAL EXAM REVIEW WITH COMPLETE 300 REAL EXAM QUESTIONS
AND CORRECT VERIFIED ANSWERS

6 ALREADY GRADED A+

7 MOST RECENT!!

8 Foundations of Pharmacology for Human Caring Nursing

9 Applied Pharmacology for Human Caring Nursing

10 Advanced Pharmacology for Human Caring Nursing

11 Pharmacology for Human Caring Nursing Review


ABSTRACT




Page 1

,This study document brings together 120 carefully worded exam questions drawn from NRG 200
FINAL EXAM NEWEST 2026 ACTUAL EXAM TEST BANK NRG200 PHARMACOLOGY FOR
HUMAN CARING NURSING FINAL EXAM REVIEW WITH COMPLETE 300 REAL EXAM
QUESTIONS AND CORRECT VERIFIED ANSWERS/ ALREADY GRADED A+ (MOST
RECENT!!), with the strongest emphasis placed on Analyze the pharmacokinetic and
pharmacodynamic processes of major drug classes and their implications for nursing care,
Evaluate the safety, efficacy, and monitoring parameters of pharmacological therapies in complex
clinical scenarios, Integrate ethical, legal and and evidence-based principles into medication
administration and patient education. Every item follows the wording style and level of reasoning
you meet in the real paper, and each one is paired with a clear rationale so the correct choice is
never a guess. Work through the set at your own pace, mark the questions that slow you down,
then come back to them until the reasoning feels automatic. Learners who revise this way walk into
the exam room recognising the pattern behind the questions instead of meeting them for the first
time. Keep going - steady, honest practice is what turns a difficult paper into a comfortable pass.




Q1 ANALYZE THE PHARMACOKINETIC AND PHARMACODYNAMIC PROCESSES OF MAJOR
DRUG CLASSES AND THEIR IMPLICATIONS FOR NURSING CARE
A patient with chronic kidney disease (CrCl 25 mL/min) is prescribed a drug that is
primarily renally excreted and has a narrow therapeutic index. The nurse reviews
the medication reconciliation and notes a potential interaction with a drug that
inhibits CYP3A4. Which adjustment is MOST appropriate to prevent toxicity?
A. Increase the dose of the renally excreted drug and monitor serum levels

B. Reduce the dose of the renally excreted drug and monitor serum levels CORRECT

C. Discontinue the CYP3A4 inhibitor and maintain the current dose

D. Administer the drug at a longer interval without changing the dose

RATIONALE: In chronic kidney disease, renal clearance is reduced, so the dose of a renally
excreted drug must be decreased to avoid accumulation. The CYP3A4 inhibitor further increases
the risk of toxicity by slowing metabolism of the drug if it is also a CYP3A4 substrate. Therefore,
dose reduction and therapeutic drug monitoring are essential. Increasing the dose (A) would
worsen toxicity; discontinuing the inhibitor (C) may not be feasible and still leaves the renal
impairment; extending the interval (D) may be appropriate but does not address the metabolic
inhibition.




Page 2

,Q2 ANALYZE THE PHARMACOKINETIC AND PHARMACODYNAMIC PROCESSES OF MAJOR
DRUG CLASSES AND THEIR IMPLICATIONS FOR NURSING CARE
A patient on long-term warfarin therapy requires an antibiotic for a urinary tract
infection. Which antibiotic class poses the HIGHEST risk of potentiating warfarin's
anticoagulant effect through both pharmacokinetic and pharmacodynamic
mechanisms?
A. Penicillins

B. Macrolides

C. Fluoroquinolones CORRECT

D. Nitrofurantoin

RATIONALE: Fluoroquinolones (e.g., ciprofloxacin) inhibit CYP1A2 and CYP3A4, reducing
warfarin metabolism, and also displace warfarin from protein binding, increasing free drug
concentration. They also disrupt gut flora, reducing vitamin K synthesis. Macrolides (B) also
inhibit CYP3A4 but are less potent and do not have the same protein-binding displacement.
Penicillins (A) have minimal interaction, and nitrofurantoin (D) is generally considered safe. Thus,
fluoroquinolones are the highest risk.




Q3 ANALYZE THE PHARMACOKINETIC AND PHARMACODYNAMIC PROCESSES OF MAJOR
DRUG CLASSES AND THEIR IMPLICATIONS FOR NURSING CARE
A patient with type 2 diabetes and chronic heart failure is prescribed a new
antidiabetic agent. Which medication is MOST appropriate given the
cardiovascular benefits and low hypoglycemia risk?
A. Sulfonylurea (glipizide)

B. SGLT2 inhibitor (empagliflozin) CORRECT

C. DPP-4 inhibitor (sitagliptin)

D. Thiazolidinedione (pioglitazone)

RATIONALE: SGLT2 inhibitors, such as empagliflozin, have demonstrated cardiovascular
benefits, including reduced heart failure hospitalizations, and carry a low risk of hypoglycemia.
They are preferred in patients with type 2 diabetes and heart failure. Sulfonylureas (A) increase
hypoglycemia risk and have no cardiovascular benefit; DPP-4 inhibitors (C) are neutral but not
preferred; thiazolidinediones (D) can worsen heart failure due to fluid retention. Therefore, SGLT2
inhibitors are the best choice.




Page 3

, Q4 ANALYZE THE PHARMACOKINETIC AND PHARMACODYNAMIC PROCESSES OF MAJOR
DRUG CLASSES AND THEIR IMPLICATIONS FOR NURSING CARE
A patient is receiving an intravenous infusion of norepinephrine for septic shock.
The nurse notes an extravasation at the insertion site. What is the MOST
appropriate immediate action?
A. Apply a warm compress and continue the infusion at a different site

B. Stop the infusion, aspirate residual drug, and administer phentolamine locally CORRECT

C. Flush the line with normal saline to dilute the drug

D. Elevate the extremity and apply a cold compress

RATIONALE: Extravasation of a vasopressor like norepinephrine causes severe vasoconstriction
and tissue ischemia. The immediate action is to stop the infusion, aspirate any residual drug from
the catheter, and inject phentolamine, an alpha-adrenergic antagonist, into the affected area to
reverse vasoconstriction. Warm compresses (A) are used for some extravasations but not for
vasopressors; flushing (C) would worsen the extravasation; elevation and cold compress (D) are
not appropriate for vasopressor extravasation.




Q5 ANALYZE THE PHARMACOKINETIC AND PHARMACODYNAMIC PROCESSES OF MAJOR
DRUG CLASSES AND THEIR IMPLICATIONS FOR NURSING CARE
A patient with major depressive disorder is prescribed a monoamine oxidase
inhibitor (MAOI) after failing SSRIs. Which dietary restriction is CRITICAL to
reinforce to prevent a hypertensive crisis?
A. Avoid foods high in tyramine, such as aged cheeses and cured meats CORRECT

B. Increase intake of foods rich in folic acid

C. Limit foods high in potassium

D. Avoid foods containing tryptophan

RATIONALE: MAOIs inhibit the breakdown of tyramine, leading to its accumulation and potential
hypertensive crisis when consumed with tyramine-rich foods like aged cheeses, cured meats,
and fermented products. Avoiding these foods is critical. Folic acid (B) is not a concern;
potassium (C) is not restricted; tryptophan (D) is not the primary concern, though it can affect
serotonin, but tyramine is the key.




Page 4

Document information

Uploaded on
September 2, 2026
Number of pages
62
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$28.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
PremiumExamBank
4.8
(1058)
Sold
441
Followers
70
Items
6911
Last sold
9 hours ago



Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions